Balducci, A.G., Colombo, G., Corace G., Cavallari, C., Rodriguez, L., Buttini, F., Colombo, P.

, Rossi, A. (2011). Layered lipid microcapsules for mesalazine delayed-release in children. Int J Pharm. 15:293-300. Bilyard, K, G., Joseph , E, C., Metcalf, R. (1990). Mesalazine: An Overview of Key Preclical Studies. Scand J Gastroenterology. 25:52-55. Bendas, E.R., Christensen, J.M., Ayres, J.W. (2010). Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets colon targeting. Drug Dev Ind Pharm. 36:393404. Brack, H.P., Tirmizi, S.A., Risen, W.M. (1997). A spectroscopic and viscosimetric study of the metal ions-induced gelation of the biopolymer chitosan. Polymer. 38:2351-2362. Dubey, R., Dubey, R., Omrey, P., Vyas, S.P., Jain, S.K. (2010). Development and characterization of colon specific drug delivery system bearing 5-ASA and camylofine dihydrochloride for the treatment of ulcerative colitis. J Drug Target. 18:589601. Ghorab, D.M., Amin, M.M., Khowessah, O.M., Tadros, M.I. (2011). Colon-targeted celecoxibloaded Eudragit S100-coated poly--caprolactone microparticles: preparation, characterization and in vivo evaluation in rats. Drug Deliv. 18:523-35. Gohel, M.C., Parikh, R.K., Nagori, S.A., Dabhi, M.R. (2008). Design of a potential colonic Drug delivery system of mesalamine Colonic Drug Delivery. Pharm Dev Technol. 13:447 456. Golden B.A. (2010) Non fluoride containing dietary supplement toothpaste and method of using the same. US patent 2010/0297197 A1 Kaur, G., Rana, V., Jain, S., Tiwary, A.K. (2010). Colon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complex. AAPS PharmSciTech. 11:3645. Krishnaiah, Y.S., Muzib, Y.I., Rao, G.S., Bhaskar, P., Satyanarayana, V. (2003). Studies on the development of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis. Drug Deliv. 10:111117. Mahkam, M. (2007). New pH-sensitive glycopolymers for colon-specific drug delivery. Drug Deliv.14:147-53. Mi, F.L., Shyu, S.S., Lee, S.T., Wong, T.B. (1999). Kinetic study of chitosan-tripolyphosphate complex reaction and acid-resistive properties of the chito-san-tripolyphosphate gel beads prepared by in-liquid curing method. J Polymer Sci Part-B Polymer Phys. 37:1551-1564. Morris, G.P., Beck, P.L., Herridge, M.S., Depew W.T., Szewezuk M.R., Wallace J.L. (1989). Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 96:795-803. Moulari, B., Pertuit, D., Pellequer, Y., Lamprecht, A. (2008). The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis. Biomaterials. 29:4554-60. Nguyen, C., Christensen, J.M., Ayres, J.W. (2012). Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon. Pharm Dev Technol. 17:73-83. Patel, M.M., Shah, T.J., Amin, A.F. (2009). Design, Development and Optimization of a Novel Time and pH-Dependent Colon Targeted Drug Delivery System Dual Coated Colon Specific Drug Delivery System. Pharm Dev Technol. 14:6572.

Quinteros, D.A., Manzo, R.H., Allemandi, D.A. (2010). Design of a colonic delivery system based on cationic polymethacrylate (Eudragit E100)-mesalamine complexes. Drug Deliv. 17:208213. Rana, V., Babita, K., Goyal, D., Gorea, R., Tiwary, A. (2004). Optimization of chitosan film as a substitute for animal and human epidermal sheets for in vitro permeation of polar and non polar drugs. Acta Pharm. 54:28799. Sandborn, W.J., Hanauer, S.B., Buch, A. (2004). Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers. Aliment Pharmacol Ther. 19:1089-98. Sinha, V.R., Kumria., R. (2003). Microbially triggered drug delivery to the colon. Eur J Pharm Sci.18:318. Singh, K., Suri, R., Tiwary, A.K., Rana, V. (2012). Chitosan films: crosslinking with EDTA modifies physicochemical and mechanical properties. J Mater Sci: Mater Med. 23:687 695. Thanou, M., Verhoef, J.C., Junginger, H.E. (2001). Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev. 50:S91-101. Tiwary, A.K., Rana, V. (2010). Cross-linked chitosan films: effect of crosslinking density on swelling parameters. Pak J Pharm Sci. 23:4438. Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, J., Yamamoto, A., Muranishi, S. (1997). Chitosan capsules for colon specific drug de-livery: Improvement of insulin absorption from the rat colon. J. Pharm. Sci. 86: 1016-1021. US Pharmacopeia XXX NF XXV. US Pharmacopeial convention, Rockville; 2007. Yehia, S.A., Elshafeey, A.H., Elsayed, I. (2011) Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation. Drug Deliv. 18:620-30. Rudolph, M.W., Klein, S., Beckert, T.E., Petereit, H., Dressman, J.B. (2001). A new 5aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. Eur J Pharm Biopharm. 51:183-90. Zhang, H., Neau, S.H. (2002). In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents. Biomaterials. 23: 27612766.